Stay updated on Pembrolizumab in Elderly Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Elderly Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Elderly Lung Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe page footer now displays Revision: v3.6.5, replacing the previous version, indicating a platform update. The study information shown remains the same.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision: v3.6.4 has been added, replacing v3.6.3 to indicate a behind-the-scenes website update. No study content or user-facing data changes are indicated.SummaryDifference0.1%

- Check49 days agoChange DetectedThe study page revision label updated from v3.6.2 to v3.6.3, reflecting a minor update to the record without changing substantive content.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page's revision tag in the footer was updated from v3.6.0 to v3.6.2, signaling a small update to the page's underlying version.SummaryDifference0.1%

- Check70 days agoChange DetectedThe study page now shows 'No longer looking for participants' and adds new sections 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', while removing the old 'Intervention / Treatment' heading and the prior 'Revision: v3.5.5' note.SummaryDifference0.4%

- Check77 days agoChange DetectedThe page's revision indicator updated from Revision: v3.5.4 to Revision: v3.5.5, signaling a minor page refresh.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Elderly Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Elderly Lung Cancer Clinical Trial page.